OxMet Technologies was founded in 2017 by researchers at Oxford University, drawing on technology and software developed over two decades. The company's mission is to develop, license, and manufacture proprietary alloys, alloy powders and alloy components for the aerospace, automotive, industrial and biomedical markets. OxMet’s proprietary ABD® range of alloys has a wide range of industrial, medical, and consumer applications, including making rockets, planes, and cars more fuel efficient, and reducing the problems associated with many medical implants.